Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Valneva SE Announces Sale of its Clinical Manufacturing Operations (CMO) in France to Biological E


Friday, 7 Jun 2013 02:01am EDT 

Valneva SE announced the signing of a binding term sheet to sell its Clinical Manufacturing Operations (CMO) in Nantes to Biological E, an Indian biopharmaceutical company. The financial terms of the deal were not disclosed. 

Company Quote

4.62
-0.07 -1.49%
7:30am EST